Search

Your search keyword '"ADINOLFI, L. E."' showing total 238 results

Search Constraints

Start Over You searched for: Author "ADINOLFI, L. E." Remove constraint Author: "ADINOLFI, L. E."
238 results on '"ADINOLFI, L. E."'

Search Results

1. Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma

2. Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic

Catalog

Books, media, physical & digital resources

5. Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy

7. Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study

8. Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial

9. Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment

22. Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9)

27. Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial

30. Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study

32. The long-term impact of renin-angiotensin system (RAS) inhibition on cardiorenal outcomes (LIRICO): A randomized, controlled trial

33. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

34. No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis

35. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

36. Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9)

37. Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study

38. Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy

39. Editorial - HCC in HCV patients and the direct acting antivirals: is there really a link?

40. Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study

41. Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience

44. Effect of hepatitis B virus on steatosis in hepatitis C virus co‐infected subjects: A multi‐centre study and systematic review.

45. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee

46. Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial

48. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study

49. Resistance to aminoglycosides and other antibiotics among clinical isolates of Enterococcus spp